Literature DB >> 2903811

Antihistamines and driving safety.

J F O'Hanlon1.   

Abstract

The results of two placebo-controlled driving performance studies confirm laboratory data showing that the nonsedating antihistamine terfenadine does not influence the driving performance of users. The amplitude of vehicle weaving calculated for drivers who received this agent did not differ from control values. Neither terfenadine nor loratadine, another nonsedating antihistamine, potentiated the adverse effects of alcohol on driving performance.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2903811

Source DB:  PubMed          Journal:  Cutis        ISSN： 0011-4162


  7 in total

Review 1.  Terfenadine. The first nonsedating antihistamine.

Authors:  H C Masheter
Journal:  Clin Rev Allergy       Date:  1993

Review 2.  Effects of terfenadine on psychomotor performance. An overview.

Authors:  D W Aaronson
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

3.  Effects of terfenadine and pseudoephedrine, alone and in combination in a nasal provocation test and in perennial rhinitis.

Authors:  S Henauer; M Seppey; C Huguenot; A Pécoud
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  H1-receptor antagonists. Comparative tolerability and safety.

Authors:  F E Simons
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 5.  Terfenadine. An updated review of its pharmacological properties and therapeutic efficacy.

Authors:  D McTavish; K L Goa; M Ferrill
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

6.  Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements.

Authors:  E F P M Vuurman; G H Rikken; N D Muntjewerff; F de Halleux; J G Ramaekers
Journal:  Eur J Clin Pharmacol       Date:  2004-05-28       Impact factor: 2.953

Review 7.  Central nervous system effects of the second-generation antihistamines marketed in Japan--review of inter-drug differences using the proportional impairment ratio (PIR)-.

Authors:  Tatsuya Isomura; Takeshi Kono; Ian Hindmarch; Norimasa Kikuchi; Aya Murakami; Kyoko Inuzuka; Seiji Kawana
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.